Life Saving Drugs Program resources – Perinatal- and infantile-onset hypophosphatasia (HPP)

A collection of resources for health professionals to help people with perinatal- or infantile-onset hypophosphatasia (HPP) access asfotase alfa (Strensiq®) under the Life Saving Drugs Program.

Cover page Life saving drug program perinatal or infantile onset hypophosphatasia HPP guidelines

Collection description

This collection contains guidelines, forms and documents related to accessing asfotase alfa (Strensiq®) under the Life Saving Drugs Program. Click to view the Strensiq® product information on the Therapeutic Goods Administration website.

Guidelines

Forms

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Audience:
Health sector

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.